{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:15:25Z","timestamp":1769595325809,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.eururo.2012.08.064","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T21:30:34Z","timestamp":1346794234000},"page":"145-154","source":"Crossref","is-referenced-by-count":68,"title":["Comparative Outcomes of Primary, Recurrent, and Progressive High-risk Non\u2013muscle-invasive Bladder Cancer"],"prefix":"10.1016","volume":"63","author":[{"given":"Francis","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidan P.","family":"Noon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Goepel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.F.","family":"Catto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2012.08.064_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2012.08.064_bib0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00345-009-0395-z","article-title":"Economic aspects of bladder cancer: what are the benefits and costs?","volume":"27","author":"Sievert","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2012.08.064_bib0015","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.064_bib0020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.eururo.2011.01.044","article-title":"MicroRNA in prostate, bladder, and kidney cancer: a systematic review","volume":"59","author":"Catto","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.064_bib0025","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.eururo.2011.03.017","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update","volume":"59","author":"Babjuk","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.064_bib0030","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.eururo.2011.03.023","article-title":"Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines","volume":"59","author":"Stenzl","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.064_bib0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2009.08.024","article-title":"An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer","volume":"57","author":"Kulkarni","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.064_bib0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2011.05.045","article-title":"Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review","volume":"60","author":"Van den Bosch","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.064_bib0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.juro.2010.03.022","article-title":"Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumours","volume":"184","author":"Alkhateeb","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.064_bib0050","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin: multivariate analysis of data from four randomized CUETO trials","volume":"53","author":"Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.064_bib0085","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1002\/cncr.27587","article-title":"The long-term outcome of treated high-risk nonmuscle-invasive bladder cancer: time to change treatment paradigm?","volume":"118","author":"Thomas","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2012.08.064_bib0060","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bmj.308.6923.257","article-title":"Proposal for changes in cystoscopic follow up of patients with bladder cancer and adjuvant intravesical chemotherapy","volume":"308","author":"Hall","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2012.08.064_bib0065","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/S0022-5347(06)00256-4","article-title":"Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumour clearance","volume":"175","author":"Catto","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.064_bib0080","doi-asserted-by":"crossref","unstructured":"Linton KD, Rosario DJ, Thomas F, et al. Disease specific mortality in patients with low risk bladder cancer and the impact of cystoscopic surveillance. J Urol. In press. http:\/\/dx.doi.org\/10.1016\/j.juro.2012.09.084.","DOI":"10.1016\/j.juro.2012.09.084"},{"key":"10.1016\/j.eururo.2012.08.064_bib0090","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1464-410X.2012.10996.x","article-title":"Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer","volume":"110","author":"Van Rhijn","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2012.08.064_bib0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0302-2838(03)00048-4","article-title":"Do prognostic parameters of remission versus relapse after bacillus Calmette-Guerin (BCG) immunotherapy exist? Analysis of a quarter century of literature","volume":"43","author":"Saint","year":"2003","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812010172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812010172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T21:25:56Z","timestamp":1542749156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283812010172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0302283812010172"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2012.08.064","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}